A detailed history of Financial Architects, Inc transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Financial Architects, Inc holds 1,706 shares of LH stock, worth $394,000. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,706
Previous 1,706 -0.0%
Holding current value
$394,000
Previous $391,000 5.12%
% of portfolio
0.06%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$203.72 - $248.97 $611 - $746
-3 Reduced 0.18%
1,706 $401,000
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $350,020 - $448,082
1,709 New
1,709 $350,000
Q2 2022

Aug 11, 2022

SELL
$213.86 - $277.87 $364,845 - $474,046
-1,706 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$251.87 - $278.14 $1,511 - $1,668
6 Added 0.35%
1,706 $471,000
Q3 2020

Nov 09, 2020

SELL
$167.03 - $201.3 $11,191 - $13,487
-67 Reduced 3.79%
1,700 $320,000
Q2 2020

Aug 11, 2020

BUY
$113.31 - $182.44 $30,253 - $48,711
267 Added 17.8%
1,767 $294,000
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $37,193 - $44,608
-258 Reduced 14.68%
1,500 $259,000
Q1 2019

May 13, 2019

BUY
$123.7 - $156.3 $217,464 - $274,775
1,758 New
1,758 $268,000
Q1 2019

May 03, 2019

SELL
$123.7 - $156.3 $214,001 - $270,399
-1,730 Closed
0 $0
Q3 2018

Oct 29, 2018

BUY
$167.67 - $188.27 $5,197 - $5,836
31 Added 1.82%
1,730 $301,000
Q2 2018

Aug 03, 2018

SELL
$160.33 - $189.41 $144,938 - $171,226
-904 Reduced 34.73%
1,699 $305,000
Q1 2018

Apr 23, 2018

BUY
$161.53 - $178.11 $147,476 - $162,614
913 Added 54.02%
2,603 $421,000
Q3 2017

Nov 01, 2017

BUY
$149.47 - $160.56 $252,604 - $271,346
1,690
1,690 $255,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Financial Architects, Inc Portfolio

Follow Financial Architects, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.